Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Rotarix in Healthy Infants
NCT00134732Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2005
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rotavirus gastroenteritis comparing HRV Vaccine with Placebo (2 arms). Primary endpoint: Percent who seroconverted (anti-rota serum IgA). Started Jul 2005; status: completed.
02
Drugs
human rotavirus vaccine, live attenuated
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT00134732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134732.